« Previous
Next »
Biology of Blood and Marrow Transplantation
Volume 12, Issue 7
, Pages 758-769
, July 2006
Impact of Donor and Recipient Sex and Parity on Outcomes of HLA-Identical Sibling Allogeneic Hematopoietic Stem Cell Transplantation
References
- Risk factors for acute graft-versus-host disease . Br J Haematol . 1987;67:397–406
- Previous donor pregnancy as a risk factor for acute graft-versus-host disease in patients with aplastic anaemia treated by allogeneic marrow transplantation . Br J Haematol . 1990;74:492–496
- . Female marrow donors increase the risk of acute graft-versus-host disease (effect of donor age and parity and analysis of cell subpopulations in the donor marrow inoculum) . Br J Haematol . 1986;63:231–239
- Risk factors for acute graft-versus-host disease in histocompatible donor bone marrow transplantation . Transplantation . 1991;51:1197–1203
- Acute graft-versus-host disease (analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate) . Blood . 1992;80:1838–1845
- Risk factors for chronic graft-versus-host disease after bone marrow transplantation (a retrospective single centre analysis) . Bone Marrow Transplant . 1998;22:755–761
- Risk factors for moderate-to-severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation . Biol Blood Marrow Transplant . 2002;8:674–682
- Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantation . Blood . 1999;94:1465–1470
- Predictive factors for acute graft-versus-host disease in patients transplanted with HLA-identical bone marrow . Blood . 1984;63:1265–1270
- . Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants . Blood . 2004;103:347–352
- Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors (the effect of donor age) . Blood . 2001;98:2043–2051
- . Fetal leukocytes in the maternal circulation after delivery. I. Cytological aspects . Transplantation . 1974;17:346–354
- . Prenatal diagnosis by analysis of fetal cells in maternal blood . J Pediatr . 1995;127:847–856
- Two-way cell traffic between mother and fetus (biologic and clinical implications) . Blood . 1996;88:4390–4395
- . Quantitative analysis of the bidirectional fetomaternal transfer of nucleated cells and plasma DNA . Clin Chem . 2000;46:1301–1309
- . Y chromosome sequence DNA amplified from peripheral blood of women in early pregnancy . Lancet . 1994;343:413–414
- . Identification of alloreactive T-cell epitopes on the Rhesus D protein . Blood . 2000;96:4011–4019
-
.
Alloimmune thrombocytopenias
.
In:
Loscalzo J
, Schafer AI
editor.
Thrombosis and Hemorrhage
. 2nd ed.. Baltimore: Williams & Wilkins; 1998;p. 599–615
- . Maternal alloimmunization to HLA, platelet and granulocyte-specific antigens during pregnancy (its influence on cord blood granulocyte and platelet counts) . Br J Haematol . 1989;71:119–123
- . A prospective study of the incidence, time of appearance and significance of anti-paternal lymphocytotoxic antibodies in human pregnancy . Hum Reprod . 1991;6:294–298
- . The interest of flow cytometry for the detection of pregnancy-induced alloimmunization . Transplant Proc . 2000;32:2747
- Pregnancy induces minor histocompatibility antigen-specific cytotoxic T cells (implications for stem cell transplantation and immunotherapy) . Blood . 2004;103:1961–1964
- . Immune complexes containing H-Y antigen and maternal IgG in cord serum . Clin Exp Immunol . 1982;50:450–453
- . Multiparity induces priming to male-specific minor histocompatibility antigen, HY, in mice and humans . Blood . 2003;102:388–393
-
Antibody responses to multiple H-Y minor histocompatibility antigens are induced after allogeneic stem cell transplantation and in normal female donors
.
Blood
. 2003;102:950a
- Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors . Blood . 2004;103:353–359
- . Recipient immune-competent T lymphocytes can survive intensive conditioning for bone marrow transplantation . Blood . 1986;68:954–956
- Rejection of bone-marrow graft by recipient-derived cytotoxic T lymphocytes against minor histocompatibility antigens . Lancet . 1990;335:131–134
- . What determines who develops graft-versus-host disease (the graft or the host (or both)?) . Bone Marrow Transplant . 1992;10:99–102
- ABO compatibility and acute graft-versus-host disease following allogeneic bone marrow transplantation . Transplantation . 1988;45:1091–1094
- . Graft-versus-host disease and survival after ABO-incompatible allogeneic bone marrow transplantation (a single-centre experience) . Br J Haematol . 2001;113:251–253
-
ABO mismatch increases transplant-related morbidity and mortality in patients given nonmyeloablative allogeneic HPC transplantation
.
Transfusion
. 2003;43:1153–1161
- Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors . Transplantation . 1974;18:295–304
- . Estimation of failure probabilities in the presence of competing risks (new representations of old estimators) . Stat Med . 1999;18:695–706
- . Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part 2: regression modeling . Bone Marrow Transplant . 2001;28:1001–1011
-
.
Controlling the false discovery rate
(a practical and powerful approach to multiple testing)
.
J R Stat Soc B
. 1995;57:289–300
- . Y-antigen killing by T cells of women is restricted by HLA . Nature . 1977;266:544–545
- Human H-Y (a male-specific histocompatibility antigen derived from the SMCY protein) . Science . 1995;269:1588–1590
- HA-1 and the SMCY-derived peptide FIDSYICQV (H-Y) are immunodominant minor histocompatibility antigens after bone marrow transplantation . Transplantation . 1998;66:910–916
- . Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum . Proc Natl Acad Sci U S A . 1996;93:705–708
- . The lost chord (microchimerism and allograft survival) . Immunol Today . 1996;17:577–584
- . Long-term fetal microchimerism in peripheral blood mononuclear cell subsets in healthy women and women with scleroderma . Blood . 1999;93:2033–2037
-
.
Fetal-maternal microchimerism
(impact on hematopoietic stem cell transplantation)
.
Curr Opin Immunol
. 2005;17–546
- Successful non-T cell-depleted HLA haplo-identical three-loci mismatched hematopoietic stem cell transplantation from mother to son based on the feto-maternal microchimerism in chronic myelogenous leukemia . Bone Marrow Transplant . 2002;30:793–796
- Non-T-cell-depleted HLA haploidentical stem cell transplantation in advanced hematologic malignancies based on the feto-maternal microchimerism . Blood . 2003;101:3334–3336
- Non-T-cell-depleted HLA haploidentical stem cell transplantation based on feto-maternal microchimerism in pediatric patients with advanced malignancies . Bone Marrow Transplant . 2004;34:373–375
- . Detection of maternal cells in human umbilical cord blood using fluorescence in situ hybridization . Blood . 1995;86:2829–2832
- Microchimerism of maternal origin persists into adult life . J Clin Invest . 1999;104:41–47
- . Detection of maternal DNA in placental/umbilical cord blood by locus-specific amplification of the noninherited maternal HLA gene . Blood . 1996;88:1494–1500
- . Search for maternal cells in human umbilical cord blood by polymerase chain reaction amplification of two minisatellite sequences . Blood . 1994;83:340–344
- . HLA class I noninherited maternal antigens in cord blood and breast milk . Hum Immunol . 2004;65:231
- Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling . Blood . 2002;99:1572–1577
- Feasibility of HLA-haploidentical hematopoietic stem cell transplantation between noninherited maternal antigen (NIMA)-mismatched family members linked with long-term fetomaternal microchimerism . Blood . 2004;104:3821–3828
- Cutting edge: persistent fetal microchimerism in T lymphocytes is associated with HLA-DQA1*0501: implications in autoimmunity . J Immunol . 2000;164:5545–5548
- . Significant fetal cell microchimerism in a nontransfused woman with hepatitis C (Evidence of long-term survival and expansion) . Hepatology . 2002;36:1295–1297
- . Microchimerism of presumed fetal origin in thyroid specimens from women (a case-control study) . Lancet . 2001;358:2034–2038
- . Multi-lineage potential of fetal cells in maternal tissue (a legacy in reverse) . J Cell Sci . 2005;118:1559–1563
- Microchimerism and HLA-compatible relationships of pregnancy in scleroderma . Lancet . 1998;351:559–562
- . Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis . N Engl J Med . 1998;338:1186–1191
- . Transfer of fetal cells with multilineage potential to maternal tissue . JAMA . 2004;292:75–80
- Male DNA in female donor apheresis and CD34-enriched products . Blood . 2003;102:3845–3847
PII: S1083-8791(06)00290-4
doi: 10.1016/j.bbmt.2006.03.015
© 2006 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Biology of Blood and Marrow Transplantation
Volume 12, Issue 7
, Pages 758-769
, July 2006
